Science Explorer Back to mapMap
Discussion
Researcher · The Fourth People's Hospital · China

Hongmei Zu

Hongmei Zu publishes mostly in Epidemiology, Hepatology and Infectious Diseases, on topics such as Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation and Hepatitis B Virus Studies.

ORCID 0000-0002-7212-0891 OpenAlex
World rank
#4,299,003
of 7,710,434 ranked researchers
Rank in China
#662,018
of 978,568
Works
18
Citations
152
Citations per work
8.4
h-index
5
i10-index 4Top 88% in Epidemiology
Hongmei Zu

What does Hongmei Zu research?

Hongmei Zu's work is mostly in Medicine (74%), Agricultural and Biological Sciences (4%), Pharmacology, Toxicology and Pharmaceutics (4%).

Health Sciences: 13 works · 73.9% of their workMedicine: 13 works · 73.9% of their workEpidemiology: 5 works · 28.3% of their workHepatology: 4 works · 21.7% of their workInfectious Diseases: 3 works · 17.4% of their workSurgery: 1 works · 6.5% of their workEverything else: 3 works · 17.5% of their workLife Sciences: 2 works · 8.6% of their workAgricultural and Biological Sciences: 1 works · 4.3% of their workAnimal Science and Zoology: 1 works · 4.3% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 4.3% of their workPharmacology: 1 works · 4.3% of their workTHEIR WORKHongmei Zu18works
Life Sciences9%Health Sciences74%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1373.9%
  2. Everything else317.5%
    1. Agricultural and Biological Sciences14.3%
    2. Pharmacology, Toxicology and Pharmaceutics14.3%
  1. 1Epidemiology28% of their works
  2. 2Hepatology22% of their works
  3. 3Infectious Diseases17% of their works
  4. 4Surgery6% of their works
  5. 5Pharmacology4% of their works
  6. 6Animal Science and Zoology4% of their works

Research topics

Which keywords describe Hongmei Zu's research?

The keywords of their largest research topics: Hepatocellular Carcinoma, Immune Response, NAFLD, NASH, Epidemiology, Hepatic Encephalopathy, Liver Cirrhosis and ACE2 Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 25 words, with their numbers
  1. Hepatocellular Carcinoma132 topics
  2. Immune Response114 topics
  3. NAFLD101 topic
  4. NASH101 topic
  5. Epidemiology83 topics
  6. Hepatic Encephalopathy71 topic
  7. Liver Cirrhosis71 topic
  8. ACE2 Receptor62 topics
  9. Antiviral Therapy62 topics
  10. Liver Disease62 topics
  11. SARS-CoV-262 topics
  12. Coronavirus52 topics
  13. Vaccine52 topics
  14. Chronic Hepatitis B31 topic
  15. Clinical Characteristics31 topic
  16. Hepatitis B Virus31 topic
  17. Hepatitis C Virus31 topic
  18. Thrombosis31 topic
  19. Treatment31 topic
  20. antibody31 topic
  21. spike protein31 topic
  22. Circovirus21 topic
  23. Drug-Induced Liver Injury21 topic
  24. Hepatotoxicity21 topic
  25. Porcine Reproductive and Respiratory Syndrome Virus21 topic

Where does Hongmei Zu work?

Hongmei Zu's main affiliation in the publication record is The Fourth People's Hospital, China.

How many publications and citations does Hongmei Zu have?

OpenAlex counts 18 works and 152 citations for Hongmei Zu, an h-index of 5, ranking #4,299,003 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hongmei Zu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.